Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR | Cracking the code: learnings from oligonucleotide method development WATCH NOW

An interview with Scott Summerfield: Emerging technologies in the bioanalytical field

6 Dec 2017
General interest

For our Spotlight on emerging technologies, we spoke to Scott Summerfield, Worldwide Head of Bioanalysis at GSK (Brentford, UK) about some of the technologies emerging in the bioanalytical field, the advantages and challenges faced with these techniques, and the scope for these technologies to advance further.

Back to our Spotlight – Emerging technologies: DMPK and bioanalysis of small molecules

 

Top content

  • AAPS PharmSci 360 2025: conference highlights
  • The NAD dash: inside the molecule making longevity a measurable science
  • From the floor at AAPS PharmSci 360 2025

Related tags

emerging technologies interview video
Previous article Next article

Related articles

16 SEP 2019 REGULATED BIOANALYSIS
GCC ICH M10: thoughts from Mike Buonarati
24 JAN 2018 INTERVIEWS
An author’s perspective: Ragu Ramanathan on an LC–MS/HRMS assay for quantifying coproporphyrins as organic anion-transporting polypeptide biomarkers
16 SEP 2019 REGULATED BIOANALYSIS
GCC ICH M10: thoughts from Chad Briscoe
26 MAR 2018 BIOMARKERS
Clinical relevance of immunogenicity: an interview with Arno Kromminga
12 AUG 2022 NEWS
Meet Sei and Orca, the deep learning models used to predict DNA organization and function
17 SEP 2018 INTERVIEWS
Ask the Experts: Kevin Vernarec
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone